AJ Lanigan: Sure. In Truth, pharma firms are producing major money with treatments like Keytruda and Opdivo that deal with PD-1 and PD-L1. Right here’s the super interesting portion: imagine checkpoints as visitors indicators. You don’t want an immune program that’s running wild just like a freight educate about a waiting for link from Social Bookmarking (3)